A detailed history of Cynosure Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Cynosure Management, LLC holds 7,707 shares of NVO stock, worth $809,697. This represents 0.13% of its overall portfolio holdings.

Number of Shares
7,707
Previous 7,921 2.7%
Holding current value
$809,697
Previous $1.13 Million 18.85%
% of portfolio
0.13%
Previous 0.18%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.07 - $145.42 $25,480 - $31,119
-214 Reduced 2.7%
7,707 $917,000
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $60,864 - $72,867
496 Added 6.68%
7,921 $1.13 Million
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $63,716 - $84,814
624 Added 9.18%
7,425 $953,000
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $21,769 - $26,151
248 Added 3.78%
6,801 $703,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $595,929 - $1.31 Million
6,553 New
6,553 $595,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Cynosure Management, LLC Portfolio

Follow Cynosure Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cynosure Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cynosure Management, LLC with notifications on news.